AzTrials
AzTrials

Mental Health and Psychological Well-BeingAI ChatbotNCT07848022

Effectiveness of a Nurse-facilitated Artificial Intelligence Chatbot on Psychological Well-being and Mental Health Stigma Among Patients With Psychiatric Disorders: A Quasi-experimental Study

A study testing Nurse-Facilitated Artificial Intelligence Chatbot in people with Mental Health and Psychological Well-Being, run by Al-Zaytoonah University of Jordan at 1 site in Jordan.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

This quasi-experimental study aims to evaluate the effectiveness of a nurse-facilitated artificial intelligence (AI) chatbot in improving psychological well-being and reducing mental health stigma among patients with psychiatric disorders. Read more about this study

Who is it for?
Ages 18 to 65 months
What is being tested?
Nurse-Facilitated Artificial Intelligence Chatbot
Could I receive a placebo?
No, everyone receives an active treatment
How many people
72 participants
Where
1 siteJordan
Study dates
11 Jan 2023to 12 May 2024
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 65 months
  • All sexes
  • No healthy volunteers
  • Child

Inclusion Criteria Adult patients aged 18-65 years. Diagnosed with a psychiatric disorder by a qualified psychiatrist. Receiving care at the selected psychiatric outpatient clinic or mental health facility.

Able to read and communicate in Arabic. Possess a smartphone or device with internet access to use the AI chatbot. Willing to participate and provide informed consent.

Exclusion Criteria Patients experiencing an acute psychiatric episode requiring immediate hospitalization.

Trial locations and contacts

1 site in 1 country.

Jordan1 site
  • Eman Shokr

    Amman

Other trials in Jordan

About this study

Official title: Effectiveness of a Nurse-Facilitated Artificial Intelligence Chatbot Intervention on Psychological Well-Being and Mental Health Stigma Among Patients With Psychiatric Disorders: A Quasi-Experimental Study

This quasi-experimental study aims to evaluate the effectiveness of a nurse-facilitated artificial intelligence (AI) chatbot in improving psychological well-being and reducing mental health stigma among patients with psychiatric disorders. Participants will receive support through an AI chatbot supervised by trained psychiatric nurses. The chatbot will provide mental health education, emotional support, coping strategies, and guidance for self-management. Outcomes will include changes in psychological well-being and levels of mental health stigma before and after the intervention. The findings may help determine whether AI-assisted nursing interventions can enhance mental health care and support recovery among individuals with psychiatric disorders.

Being tested
Nurse-Facilitated Artificial Intelligence Chatbot
Keywords
Artificial Intelligence Chatbot AI Mental Health Intervention Nurse-Facilitated Intervention Psychological Well-Being Mental Health Stigma
Medical subject headings
Psychological Well-Being

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Nurse-Facilitated Artificial Intelligence ChatbotBehavioural

    A nurse-facilitated artificial intelligence chatbot designed to provide psychoeducational information, emotional support, coping strategies, and mental health guidance for patients with psychiatric disorders. The chatbot is supervised by psychiatric nurses and aims to improve psychological well-being and reduce mental health stigma.

Study groups in NCT07848022
Study groupRoleWhat they receive
Usual Care Control GroupNo interventionParticipants receive the standard psychiatric care routinely provided by the healthcare facility, including regular psychiatric consultations, prescribed treatment, and follow-up services. Participants in this arm do not receive access to the nurse-facilitated artificial intelligence chatbot during the study period. Outcome measures are assessed at the same time points as the intervention group for comparison purposes.
Nurse-Facilitated AI Chatbot InterventionExperimentalParticipants receive the standard psychiatric care routinely provided by the healthcare facility, including regular psychiatric consultations, prescribed treatment, and follow-up services. Participants in this arm do not receive access to the nurse-facilitated artificial intelligence chatbot during the study period. Outcome measures are assessed at the same time points as the intervention group for comparison purposes.
Receives: Behavioral: Nurse-Facilitated Artificial Intelligence Chatbot

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Psychological Well-being

    Change in psychological well-being scores among patients with psychiatric disorders following participation in the nurse-facilitated artificial intelligence chatbot intervention.

    Measured: Baseline (pre-intervention) and 2 weeks post-intervention Baseline (pre-intervention) and 4 weeks post-intervention Baseline (pre-intervention) and 3 months post-intervention

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted29 Sep 2026
  2. Study start11 Jan 2023
  3. Primary completion11 Apr 2023
  4. Study completion12 May 2024

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Prevention
Allocation
Non-randomised
Intervention model
Parallel groups
Model description
This is a quasi-experimental, nonrandomized study evaluating the effect of a nurse-facilitated AI chatbot intervention on psychological well-being and mental health stigma among patients with psychiatric disorders.
Masking
Single blind
Who is masked
Participant
Enrolment
72 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07848022
Sponsor's protocol ID
AlZaytoonahU
Acronym
AI Chatbot
Status last verified
Sep 2026
First submitted
31 Jul 2026
Last updated
29 Sep 2026
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Yes

Publications

  • 16. Ryff C. D. (2014). Psychological well-being revisited: advances in the science and practice of eudaimonia. Psychotherapy and psychosomatics, 83(1), 10-28. https://doi.org/10.1159/000353263. 17. Yasuhara, K., Formon, D. L., Phillips, S. & Yenne, E. M. Mental health stigma scale [Database record]. APA PsycTests (2019). https://doi.org/10.1037/t76798-000 18. Andersen, S. M., Randers, A., Jensen, C. M., Bisgaard, C., & Steinhausen, H. C. (2013). Preceding diagnoses to young adult bipolar disorder and schizophrenia in a nationwide study. BMC psychiatry, 13, 343. https://doi.org/10.1186/1471-244X-13-343 19. McKenzie, S. K., Oliffe, J. L., Black, A., & Collings, S. (2022). Men's Experiences of Mental Illness Stigma Across the Lifespan: A Scoping Review. American journal of men's health, 16(1), 15579883221074789. https://doi.org/10.1177/15579883221074789 20. Kirkbride, J. B., Anglin, D. M., Colman, I., Dykxhoorn, J., Jones, P. B., Patalay, P., Pitman, A., Soneson, E., Steare, T., Wright, T., & Griffiths, S. L. (2024). The social determinants of mental health and disorder: evidence, prevention and recommendations. World psychiatry: official journal of the World Psychiatric Association (WPA), 23(1), 58-90. https://doi.org/10.1002/wps.21160 21. Waqas, A., Malik, S., Fida, A., Abbas, N., Mian, N., Miryala, S., Amray, A. N., Shah, Z., & Naveed, S. (2020). Interventions to Reduce Stigma Related to Mental Illnesses in Educational Institutes: a Systematic Review. The Psychiatric quarterly, 91(3), 887-903. https://doi.org/10.1007/s11126-020-09751-4

Questions about this trial

What is this clinical trial studying?

A study testing Nurse-Facilitated Artificial Intelligence Chatbot in people with Mental Health and Psychological Well-Being, run by Al-Zaytoonah University of Jordan at 1 site in Jordan.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 29 Sep 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Jordan. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Psychological Well-being (time frame: Baseline (pre-intervention) and 2 weeks post-intervention Baseline (pre-intervention) and 4 weeks post-intervention Baseline (pre-intervention) and 3 months post-intervention). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT07848022, which also lists 1 linked publication.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 29 Sep 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in